from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. A drug, having a phospholipid moiety, used to treat osteosarcoma


Sorry, no etymologies found.


  • He added that a drug called mifamurtide, which had been shown in the US to improve survival by 7-8%, was currently under consideration by the National Institute of Health and Clinical Excellence (NICE).

    BBC News | News Front Page | UK Edition

  • "After further careful consideration ... the committee was able to recommend mifamurtide for osteosarcoma."

    Reuters: Press Release

  • "This clarification, along with a revised patient-access scheme, means that the extra cost per unit of health gained that the NHS will be asked to pay for mifamurtide is now lower than previously determined, but still above the normal range," Andrew Dillon, NICE's chief executive, said.

    Reuters: Press Release

  • The National Institute for Health and Clinical Excellence NICE had said in October that while there was evidence Mepact, known generically as mifamurtide, could be more effective when combined with chemotherapy than chemotherapy alone, there was uncertainty about its cost-benefit balance.

    Reuters: Press Release

  • In the three months since the election, the watchdog has turned down ten other life prolonging drugs for various cancers, including mifamurtide for a type of bone cancer which affects children.

    Home | Mail Online

  • In the ten weeks since the election, Nice has turned down or provisionally rejected ten life-prolonging drugs for various cancers, including mifamurtide for a type of bone cancer which affects children.

    Home | Mail Online

  • Com, alphabetical reflecting of all new drug applications, fda pharmacy rimonabant processlatest new drug applicationsl-mtp-pe (mifamurtide) injection


  • MEPACT (mifamurtide, L-MTP-PE) is an immune-based therapy, that when combined with chemotherapy, resulted in approximately a 30 percent decrease in the risk of death with 78 percent of patients surviving more than six years following treatment.

    GEN News Highlights

  • Institute for Health and Clinical Excellence (NICE) has refused to recommend the first treatment shown to improve survival in childhood bone cancer (osteosarcoma) in more than 20 years (1,2) - Data shows Mepact (R) (mifamurtide) reduces the risk of death by almost one third when added to standard chemotherapy treatment, compared with chemotherapy alone (3) - Using

    RedOrbit News - Technology


Log in or sign up to get involved in the conversation. It's quick and easy.